[go: up one dir, main page]

NO996492L - Oppløsningsdoseringsformer av sertralin innkapslet i gelatin - Google Patents

Oppløsningsdoseringsformer av sertralin innkapslet i gelatin

Info

Publication number
NO996492L
NO996492L NO996492A NO996492A NO996492L NO 996492 L NO996492 L NO 996492L NO 996492 A NO996492 A NO 996492A NO 996492 A NO996492 A NO 996492A NO 996492 L NO996492 L NO 996492L
Authority
NO
Norway
Prior art keywords
sertraline
gelatin
encapsulated
dosage forms
solution dosage
Prior art date
Application number
NO996492A
Other languages
English (en)
Other versions
NO996492D0 (no
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996492(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO996492D0 publication Critical patent/NO996492D0/no
Publication of NO996492L publication Critical patent/NO996492L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO996492A 1997-07-01 1999-12-27 Oppløsningsdoseringsformer av sertralin innkapslet i gelatin NO996492L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (2)

Publication Number Publication Date
NO996492D0 NO996492D0 (no) 1999-12-27
NO996492L true NO996492L (no) 2000-02-29

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996492A NO996492L (no) 1997-07-01 1999-12-27 Oppløsningsdoseringsformer av sertralin innkapslet i gelatin

Country Status (40)

Country Link
EP (1) EP0980241B1 (no)
JP (1) JP3585245B2 (no)
KR (1) KR100371730B1 (no)
CN (1) CN1261792A (no)
AP (1) AP945A (no)
AR (1) AR015916A1 (no)
AT (1) ATE256457T1 (no)
AU (1) AU724635B2 (no)
BG (1) BG103917A (no)
BR (1) BR9809712A (no)
CA (1) CA2290973C (no)
CO (1) CO4940405A1 (no)
DE (1) DE69820608T2 (no)
DK (1) DK0980241T3 (no)
DZ (1) DZ2544A1 (no)
EA (1) EA001905B1 (no)
ES (1) ES2210760T3 (no)
GT (1) GT199800090A (no)
HR (1) HRP980378B1 (no)
HU (1) HUP0002250A3 (no)
ID (1) ID24673A (no)
IL (1) IL133075A0 (no)
IS (1) IS5266A (no)
MA (1) MA24586A1 (no)
MY (1) MY119728A (no)
NO (1) NO996492L (no)
NZ (1) NZ501252A (no)
OA (1) OA11246A (no)
PA (1) PA8454001A1 (no)
PE (1) PE97299A1 (no)
PL (1) PL337807A1 (no)
PT (1) PT980241E (no)
SK (1) SK282914B6 (no)
TN (1) TNSN98123A1 (no)
TR (1) TR199903282T2 (no)
TW (1) TW382597B (no)
UA (1) UA68350C2 (no)
UY (1) UY25070A1 (no)
WO (1) WO1999001113A1 (no)
ZA (1) ZA985709B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04868B1 (et) * 1998-10-13 2007-08-15 Pfizer Products Inc. Farmatseutiline kompositsioon, mis sisaldab vett mittesisaldavat, vedelat kontsentraati oraalseks manustamiseks, mis sisaldab sertraliini v?i selle farmatseutiliselt vastuv?etava soola kogust ning hte v?i rohkemat vett mittesisaldavat farmatseutilis
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
SI1225881T1 (sl) 1999-09-03 2006-06-30 Apbi Holdings Llc Uporaba dapoksetina, selektivnega zaviralca ponovnega privzema serotonina s hitrim pricetkom delovanja, za zdravljenje seksualne disfunkcije
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
JP2006507309A (ja) * 2002-10-31 2006-03-02 アルザ・コーポレーシヨン 疎水性薬剤の上昇した生物学的利用性を提供する製剤
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
GB2630572A (en) 2023-05-29 2024-12-04 Novumgen Ltd An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782445B1 (en) * 1994-09-19 2002-03-13 Dupont Pharmaceuticals Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
EP0768083B1 (en) * 1995-07-17 2003-03-26 Pfizer Inc. Sertraline for treating post myocardial infarction patients

Also Published As

Publication number Publication date
PT980241E (pt) 2004-03-31
JP3585245B2 (ja) 2004-11-04
EP0980241B1 (en) 2003-12-17
UA68350C2 (en) 2004-08-16
IS5266A (is) 1999-11-23
AP945A (en) 2001-02-28
SK282914B6 (sk) 2003-01-09
KR100371730B1 (ko) 2003-02-07
TR199903282T2 (xx) 2000-08-21
ATE256457T1 (de) 2004-01-15
CA2290973C (en) 2003-06-17
DK0980241T3 (da) 2004-04-05
KR20010013588A (ko) 2001-02-26
HUP0002250A2 (hu) 2000-12-28
HRP980378B1 (en) 2001-12-31
MA24586A1 (fr) 1998-12-31
WO1999001113A1 (en) 1999-01-14
JP2000512316A (ja) 2000-09-19
OA11246A (en) 2002-11-19
NZ501252A (en) 2004-11-26
BR9809712A (pt) 2000-07-11
AP9801279A0 (en) 1998-06-30
NO996492D0 (no) 1999-12-27
TNSN98123A1 (fr) 2005-03-15
AU724635B2 (en) 2000-09-28
AR015916A1 (es) 2001-05-30
CO4940405A1 (es) 2000-07-24
IL133075A0 (en) 2001-03-19
SK180599A3 (en) 2001-01-18
PA8454001A1 (es) 2000-05-24
DE69820608D1 (de) 2004-01-29
CA2290973A1 (en) 1999-01-14
DE69820608T2 (de) 2004-12-23
ID24673A (id) 2000-07-27
GT199800090A (es) 1999-12-21
CN1261792A (zh) 2000-08-02
DZ2544A1 (fr) 2003-02-08
EA199900963A1 (ru) 2000-08-28
TW382597B (en) 2000-02-21
BG103917A (bg) 2000-07-31
PE97299A1 (es) 1999-10-13
ZA985709B (en) 2000-01-10
PL337807A1 (en) 2000-09-11
MY119728A (en) 2005-07-29
HRP980378A2 (en) 1999-04-30
UY25070A1 (es) 2000-12-29
AU7545098A (en) 1999-01-25
HUP0002250A3 (en) 2001-01-29
ES2210760T3 (es) 2004-07-01
EP0980241A1 (en) 2000-02-23
EA001905B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
NO944046D0 (no) Ökning av medikamentrespons
DE19681727T1 (de) Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
DE69535102D1 (de) Einkapselung von optoelektronischen bauteilen
FI972555L (fi) Päällystettyjen tablettien valmistus
FI934128A7 (fi) Uudenlaisia koteloituja aineita
NO996518L (no) Sertralinsalter og doseringsformer av sertralin med vedvarende frigjøring
ID17794A (id) Bentuk dosis gelatin lunak multi fasa
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
NO996492L (no) Oppløsningsdoseringsformer av sertralin innkapslet i gelatin
DE69801392D1 (de) Herstellung von Methylchlorid
ATE245415T1 (de) Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe
EA199900672A1 (ru) Гомеопатическое лекарственное средство
EA199900673A1 (ru) Гомеопатическое лекарственное средство
DE59807819D1 (de) Duftstoff-enthaltende Zubereitung
DE59804303D1 (de) Herstellung von Polyenaldehyden
DE59812225D1 (de) Einkapseln von wasserunlöslichen wirkstoffen mit amphiphilem charakter
DE69811864D1 (de) Herstellung von bandförmigen werkstücken
SI0980241T1 (en) Gelatine encapsulated solution dosage forms of sertraline
DE69613921D1 (de) Herstellung von Methylaminen
DE59803609D1 (de) Behandlung von Kunststoffoberflächen
SE8900772D0 (sv) Anvaending av gelatinhydrolysat i konfektyr
UA1957S (uk) Етикетка медичного препарату "аспаркам"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application